- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 11, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,599 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
A178320 | ₩26,300.00 | -2.4% | 50.9% | ₩976.0b | ₩31,000.00 | PS1.3x | E87.5% | 0.6% | Tech | ||
BOE | AU$5.78 | 8.9% | 109.4% | AU$2.4b | AU$5.74 | PE32.5x | E32.1% | n/a | Energy | ||
HHR | AU$0.007 | 0% | -76.7% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
7373 | JP¥1,691.00 | 0.2% | -33.2% | JP¥25.8b | JP¥4,600.00 | PE22.7x | E28.1% | n/a | Commercial Services | ||
3DA | AU$0.48 | 11.6% | 269.2% | AU$260.0m | n/a | PS309.9x | E80.5% | n/a | Capital Goods | ||
CTT | AU$3.08 | 2.3% | 67.4% | AU$1.3b | AU$4.26 | PE60.7x | E29.9% | n/a | Retail | ||
CAI | AU$0.13 | 4.0% | -29.7% | AU$99.0m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
CYC | AU$1.72 | -4.4% | -14.0% | AU$162.0m | AU$4.35 | PS6x | E89.2% | 0% | Healthcare | ||
4480 | JP¥3,600.00 | 1.3% | -4.0% | JP¥116.5b | JP¥5,865.00 | PE45.4x | E23.6% | n/a | Healthcare | ||
5038 | JP¥1,457.00 | 8.5% | -29.4% | JP¥21.8b | n/a | PE35.6x | E24.7% | n/a | Healthcare | ||
3029 | CN¥26.91 | -2.4% | -14.8% | CN¥5.3b | n/a | PS12.7x | E69.2% | 0% | Software | ||
666 | HK$15.00 | 2.2% | n/a | HK$34.2b | HK$16.93 | PS2.3x | E97.0% | n/a | Capital Goods | ||
9992 | HK$35.20 | 1.3% | 85.5% | HK$46.6b | HK$34.01 | PE39.8x | E23.2% | 0.9% | Retail | ||
8299 | NT$693.00 | -2.4% | 83.1% | NT$137.2b | NT$693.44 | PE37.8x | E34.7% | 1.9% | Semiconductors | ||
300896 | CN¥215.54 | 0.3% | -40.5% | CN¥64.8b | CN¥315.86 | PE32.9x | E25.2% | 1.5% | Pharmaceuticals & Biotech | ||
A254490 | ₩18,260.00 | -1.8% | -8.4% | ₩263.6b | n/a | PE52.1x | E75.7% | n/a | Tech | ||
301358 | CN¥39.90 | 13.9% | -6.6% | CN¥30.2b | n/a | PE20.7x | E30.3% | 1.0% | Capital Goods | ||
517146 | ₹341.80 | -7.8% | 47.6% | ₹104.2b | ₹471.00 | PE24.6x | E26.1% | 0.8% | Materials | ||
RDUE | €9.65 | 0% | -0.5% | €60.3m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
RCEL | US$8.26 | -5.6% | -31.8% | US$213.1m | US$25.90 | PS4.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł2.14 | 7.0% | 25.9% | zł74.9m | zł3.71 | PE14.8x | E29.0% | n/a | Diversified Financials | ||
FDE | €35.95 | 5.7% | 0% | €188.0m | €64.07 | PE23.9x | E37.6% | n/a | Energy | ||
KEBNI B | kr1.47 | -2.4% | 39.6% | kr397.5m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
AESI | US$22.72 | 3.4% | 34.6% | US$2.5b | US$26.00 | PE20.1x | E49.3% | 3.7% | Energy |